Theo chúng tôi trong thời gian tới nếu có điều kiện chúng ta cần tiến hành một số nghiên cứu sau:
- So sánh hiệu quả điều trị của phác đồ ba thuốc trong 2 tuần và phác đồ
trình tự trong 2 tuần.
- Nghiên cứu sử dụng kỹ thuật PCR để phát hiện sớm kháng thuốc tiên phát của vi khuẩn giúp cho lựa chọn kháng sinh phục vụđiều trị.
1. Nguyễn Văn Bàng (2004)., Giá trị huyết thanh học trong chẩn đoán Helicobacter pylori ở trẻ em có hội chứng dạ dày., TCNCYH (29) 3, 18-23.
2. Nguyễn Văn Bàng (2004)., Nghiên cứu một số đặc điểm dịch tễ học nhiễm Helicobacter pylori ở trẻ em tại khoa Nhi Bệnh viện Bạch Mai.,
Nghiên cứu Y học, ĐHYHN, tập 28, số 2, trang 74-80.
3. Nguyễn Văn Bàng (2005)., Một số đặc điểm dịch tễ học nhiễm Helicobacter pylori ở trẻ em Việt Nam., Tạp chí nghiên cứu Y Học 35 (2) 14-9
4. Nguyễn Thị Hòa Bình (2001)., Nghiên cứu chẩn đoán viêm dạ dày mãn tính bằng nội soi, mô bệnh học và tỷ lệ nhiệm HP., Luận án tiến sỹ Y học, ĐH YHN.
5. Nguyễn Ngọc Chức, Nguyễn Khánh Trạch, Trần Văn Hợp (2000).,
Nghiên cứu mối liên quan giữa tỉ lệ viêm dạ dày, viêm hành tá tràng mãn tính và nhiễm Helicobacter pylori ở bệnh nhân loét hành tá tràng., Nội khoa 2000, 1: 48-52.
6. Nguyễn Gia Khánh, Nguyễn Văn Bàng (2009)., Nhiễm Helicobacter pylori ở trẻ em lâm sàng và điều trị., Nhà xuất bản Y Học.
7. Nguyễn Thị Việt Hà, Phan Thị Hiền, Trần Văn Quang, Nguyễn Gia Khánh (2010)., Đặc điểm lâm sàng và cận lâm sàng của viêm, loét dạ
dày tá tràng do Helicobacter pylori ở trẻ em., Tạp chí Nhi Khoa 2010, trang 204-210.
8. Nguyễn Thị Việt Hà, Nguyễn Gia Khánh (2010)., Nghiên cứu tình trạng kháng kháng sinh ở trẻ em bị viêm dạ dày tá tràng có nhiễm Helicobacter pylori tại Bệnh viện Nhi Trung Ương; Tạp chí Nhi Khoa 2010, trang 211-217
cứu đặc điểm lâm sàng, nội soi mô bệnh học và điều trị., Luận văn Tiến sĩ y học, ĐHYHN.
10. Trần Văn Quang, Chu Văn Tường, Nguyễn Gia Khánh, Đỗ Mai Hương (2002)., Nhận xét tình hình loét dạ dày – tá tràng ở trẻ em., Nhi khoa, NXBYH 10 trang 269-77.
11. Lê Thọ, Nguyễn Gia Khánh (2008)., Đánh giá tác dụng điều trị viêm dạ dày có nhiễm Helicobacter pylori bằng phác đồ OAC(omeprazole, amoxicillin,clarithromycin) tại Bệnh viện Nhi Trung Ương., Luận văn tốt nghiệp BSCK2, ĐHYHN, 2005.
12. Trần Thiện Trung (2002)., Viêm loét dạ dày - tá tràng và vai trò của Helicobacter pylori., Nhà xuất bản Y Học; p13-112.
13. Ashorn, M., T. Ruuska, and A. Makipernaa (2001)., Helicobacter pylori and iron deficiency anaemia in children., Scand J Gastroenterol, 36(7): p. 701-5.
14. Barabino, A (2002)., Helicobacter pylori-related iron deficiency anemia: a review., Helicobacter, 7(2): p. 71-5.
15. Cardenas, V.M., et al (2006)., Iron deficiency and Helicobacter pylori infection in the United States., Am J Epidemiol, 163(2): p. 127-34.
16. Chey, W.D. and B.C. Wong (2007)., American College of Gastroenterology guideline on the management of Helicobacter pylori infection., Am J Gastroenterol, 102(8): p. 1808-25.
17. Chisholm, S.A. and R.J. Owen (2008)., Application of polymerase chain reaction-based assays for rapid identification and antibiotic resistance screening of Helicobacter pylori in gastric biopsies., Diagn Microbiol Infect Dis, 61(1): p. 67-71.
18. Chong, S.K., et al (2003)., The seroprevalence of Helicobacter pylori in a referral population of children in the United States., Am J Gastroenterol, 98(10): p. 2162-8.
System in Helicobacter pylori-associated gastritis in children., Acta Gastroenterol Latinoam, 30:35-40.
20. Das, B.K., et al (2003)., Helicobacter pylori infection and recurrent abdominal pain in children., J Trop Pediatr, 49(4): p. 250-2.
21. De Francesco V, Zullo A, Hassan C, et al (2004)., The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study., Dig Liver Dis, 36: 322–26.
22. De Francesco V, Zullo A, Margiotta M, et al (2004)., Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure., Aliment Pharmacol Ther, 19: 407–14.
23. Dixon, M.F., et al (1996)., Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994., Am J Surg Pathol, 20(10): p. 1161-81. 24. Elitsur, Y., et al (2008)., Does Helicobacter pylori protect children
from reflux disease?., J Clin Gastroenterol, 42(2): p. 215-6.
25. Enroth, H., et al (1999)., In vitro aging of Helicobacter pylori: changes in morphology, intracellular composition and surface properties.,
Helicobacter, 4(1): p. 7-16.
26. Fallone, C.A., et al (2000)., Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol, 95(4): p. 914-20.
27. Fox, M. and I. Forgacs (2006)., Gastro-oesophageal reflux disease.,
Bmj, 332(7533): p. 88-93.
28. Franchini, M., et al (2007)., Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis., J Antimicrob Chemother, 60(2): p. 237-46.
Treatment for Helicobacter pylori Eradication in Children: A Randomized Trial., Gastroenterology Volume 129, Issue 5 , Pages 1414-1419.
30. Fuccio, L., et al (2008)., Treatment of Helicobacter pylori infection.,
Bmj, 337: p. a1454.
31. Gasbarrini, A., et al (1998)., Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori., Lancet, 352(9131): p. 878.
32. Gatta, L., et al (2003)., Non-invasive techniques for the diagnosis of Helicobacter pylori infection., Clin Microbiol Infect, 9(6): p. 489-96. 33. Gatta, L., et al (2009)., Sequential Therapy or Triple Therapy for
Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Randomized Controlled Trials in Adults and Children., Am J Gastroenterol.
34. Gisbert, J.P., et al (2000)., Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori., Aliment Pharmacol Ther, 14(10): p. 1319-28. 35. Gisbert, J.P., F. de la Morena, and V. Abraira (2006)., Accuracy of
monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis., Am J Gastroenterol, 101(8): p. 1921-30.
36. Goggin, N., et al (1998)., Effect of Helicobacter pylori eradication on the natural history of duodenal ulcer disease., Arch Dis Child, 79(6): p. 502-5.
37. Gold, B.D., et al (2000)., Helicobacter pylori infection in children: recommendations for diagnosis and treatment., J Pediatr Gastroenterol Nutr, 31(5): p. 490-7.
Helicobacter pylori (Campylobacter pylori)., Eur J Clin Microbiol Infect Dis, 9(1): p. 1-13.
39. Guarner, J., et al (2009)., Helicobacter pylori diagnostic tests in children: review of the literature from 1999 to 2009., Eur J Pediatr. 40. Hardikar, W., et al (1996)., Helicobacter pylori and recurrent
abdominal pain in children., J Pediatr Gastroenterol Nutr, 22(2): p. 148-52.
41. Hirschl, A.M. and A. Makristathis (2007)., Methods to detect Helicobacter pylori: from culture to molecular biology., Helicobacter, 12 Suppl 2: p. 6-11.
42. Hoang, T.T., et al (2005)., Seroprevalence of Helicobacter pylori infection in urban and rural Vietnam., Clin Diagn Lab Immunol, 12(1): p. 81-5.
43. Huang, F.C., et al (1999)., Long-term follow-up of duodenal ulcer in children before and after eradication of Helicobacter pylori., J Pediatr Gastroenterol Nutr, 28(1): p. 76-80.
44. Jafri, MD, MSc; Carlton A. Hornung, PhD, MPH; and Colin W. Howden, MD (2008)., Meta-analysis: Sequential Therapy Appears Superior to Standard Therapy for Helicobacter pylori Infection in Patients Naive to Treatment., Ann Intern Med, 148:923-931.
45. Jaing, T.H., et al (2003)., Efficacy of Helicobacter pylori eradication on platelet recovery in children with chronic idiopathic thrombocytopenic purpura., Acta Paediatr, 92(10): p. 1153-7.
46. J. L. Tong PhD, Z. H. Ran MD, J. Shen PhD and S. D. Xiao MD (2009)., Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis., Journal of Clinical Pharmacy and Therapeutics, 34, 41–53.
Helicobacter pylori in Children., Antimicrobial Agents and Chemotherapy, Vol. 45, No. 7, p. 2134-2135.
48. Kalach N, Benhamou PH, Raymond J (1997)., Helicobacter pylori gastric infections in children., Presse Med ;26:1688-94.
49. Kandulski, A., M. Selgrad, and P. Malfertheiner (2008)., Helicobacter pylori infection: a clinical overview., Dig Liver Dis, 40(8): p. 619-26. 50. Khurana, R., et al (2005)., An update on anti-Helicobacter pylori
treatment in children., Can J Gastroenterol, 19(7): p. 441-5.
51. Khurana, R., et al (2007)., Meta-analysis: Helicobacter pylori eradication treatment efficacy in children., Aliment Pharmacol Ther, 25(5): p. 523-36.
52. Koh H, Noh TW, Baek SY (2007)., Nodular gastritis and pathologic findings in children and young adults with Helicobacter pylori infection., Yonsei medical journal;48:240-6.
53. Koike, T., et al (2001)., Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion., Gut, 49(3): p. 330-4.
54. Koletzko, S., et al (2006)., Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe., Gut, 55(12): p. 1711-6.
55. Konno, M., et al (2000)., Iron-deficiency anemia associated with Helicobacter pylori gastritis., J Pediatr Gastroenterol Nutr, 31(1): p. 52-6.
56. Konturek, J.W (2003)., Discovery by Jaworski of Helicobacter pylori and its pathogenetic role in peptic ulcer, gastritis and gastric cancer., J Physiol Pharmacol, 54 Suppl 3: p. 23-41.
Helicobacter pylori in peptic ulcer disease., Aliment Pharmacol Ther, 9 Suppl 2: p. 59-69.
58. Kurekci, A.E., et al (2004)., Complete platelet recovery after treatment of Helicobacter pylori infection in a child with chronic immune thrombocytopenic purpura: a case report., Pediatr Hematol Oncol, 21(7): p. 593-6.
59. Kusters, J.G., A.H. van Vliet, and E.J. Kuipers (2006)., Pathogenesis of Helicobacter pylori infection., Clin Microbiol Rev, 19(3): p. 449-90. 60. Kusters, J.G., et al (1997)., Coccoid forms of Helicobacter pylori are
the morphologic manifestation of cell death., Infect Immun, 65(9): p. 3672-9.
61. Macarthur, C., et al (1999)., Helicobacter pylori and childhood recurrent abdominal pain: community based case-control study., Bmj, 319(7213): p. 822-3.
62. Malfertheiner, P., et al (2007)., Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.,
Gut, 56(6): p. 772-81.
63. Marshall, B.J. and J.R. Warren (1984)., Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration., Lancet, 1(8390): p. 1311-5.
64. Marshall, B.J., et al (1985)., Attempt to fulfil Koch's postulates for pyloric Campylobacter., Med J Aust, 142(8): p. 436-9.
65. Masoodpoor, N., Darakhshan, and M. Sheikhvatan (2008).,
Helicobacter pylori infection in Iranian children with recurrent abdominal pain., Trop Gastroenterol, 29(4): p. 221-3.
66. Megraud, F. and P. Lehours (2007)., Helicobacter pylori detection and antimicrobial susceptibility testing., Clin Microbiol Rev, 20(2): p. 280- 322.
importance, and advances in testing., Gut, 53(9): p. 1374-84.
68. Moayyedi, P (2007)., Sequential regimens for Helicobacter pylori eradication., Lancet, 370(9592): p. 1010-2.
69. Moujaber, T., et al (2008)., The seroepidemiology of Helicobacter pylori infection in Australia., Int J Infect Dis, 12(5): p. 500-4.
70. Mukherjee, P., et al (2005)., Prevalence of Helicobacter pylori infection in children with recurrent abdominal pain., Trop Gastroenterol, 26(2): p. 102-4.
71. Nakamura, R.M (2001)., Laboratory tests for the evaluation of Helicobacter pylori infections., J Clin Lab Anal, 15(6): p. 301-7.
72. Naous, A., et al (2007)., Fecoprevalence and determinants of Helicobacter pylori infection among asymptomatic children in Lebanon., J Med Liban, 55(3): p. 138-44.
73. Ndip, R.N., et al (2003)., Culturing Helicobacter pylori from clinical specimens: review of microbiologic methods., J Pediatr Gastroenterol Nutr, 36(5): p. 616-22.
74. Ndip, R.N., et al (2004)., Helicobacter pylori antigens in the faeces of asymptomatic children in the Buea and Limbe health districts of Cameroon: a pilot study., Trop Med Int Health, 9(9): p. 1036-40.
75. Nguyen, B.V., et al (2006)., Prevalence of and factors associated with Helicobacter pylori infection in children in the north of Vietnam., Am J Trop Med Hyg, 74(4): p. 536-9.
76. Oberhuber, G., et al (1998)., Significant improvement of atrophy after eradication therapy in atrophic body gastritis., Pathol Res Pract, 194(9): p. 609-13.
77. Pandolfino JE, Howden CW, Kahrilas PJ (2004)., H. pylori and GERD: Is less more? Am J Gastroenterol, 99:1222–5.
gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection., Gut, 40: 297-301.
79. Parsonnet, J. and P.G. Isaacson (2004)., Bacterial infection and MALT lymphoma., N Engl J Med, 350(3): p. 213-5.
80. Parsonnet, J., H. Shmuely, and T. Haggerty (1999)., Fecal and oral shedding of Helicobacter pylori from healthy infected adults., JAMA, 282(23): p. 2240-5.
81. Prentice, A.M. and M.K. Darboe (2008)., Growth and host-pathogen interactions., Nestle Nutr Workshop Ser Pediatr Program, 61: p. 197- 210.
82. Rafeey, M., et al (2007)., Primary resistance in Helicobacter pylori isolated in children from Iran., J Infect Chemother, 13(5): p. 291-5. 83. Raghunath AS, Hungin APS, Wooff D, et al (2004)., Systematic
review: The effect of Helicobacter pylori and its eradication on gastro- oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis., Aliment Pharmacol Ther, 20:733–44.
84. Ricci, C., J. Holton, and D. Vaira (2007)., Diagnosis of Helicobacter pylori: invasive and non-invasive tests., Best Pract Res Clin Gastroenterol, 21(2): p. 299-313.
85. Riddell RH (1999)., Pathobiology of Helicobacter pylori infection in children., Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 13:599-603.
86. Roma, E., et al (2001)., Is peptic ulcer a common cause of upper gastrointestinal symptoms? Eur J Pediatr, 160(8): p. 497-500.
87. Saad, R.J. and W.D. Chey (2007)., Breath tests for gastrointestinal disease: the real deal or just a lot of hot air? Gastroenterology, 133(6): p. 1763-6.
infection in children: management and pharmacotherapy., Expert Opin Pharmacother, 9(4): p. 577-85.
89. Scaccianoce G, Hassan C, Panarese A, Piglionica D, Morini S, Zullo A (2006)., Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen., Can J Gastroenterol, 20: 113–17.
90. Scott, D.R., et al (1998)., The role of internal urease in acid resistance of Helicobacter pylori., Gastroenterology, 114(1): p. 58-70.
91. Sedlackova, M., et al (2003)., [Helicobacter pylori infection in a group of symptomatic and asymptomatic children and adolescents in the Czech Republic., Cas Lek Cesk, 142(2): p. 102-5.
92. Selgrad, M. and P. Malfertheiner (2008)., New strategies for Helicobacter pylori eradication., Curr Opin Pharmacol, 8(5): p. 593-7. 93. Shehada, S., I. Srugo, and R. Shaoul (2007)., Failure of sequential
therapy to eradicate Helicobacter pylori in previously treated subjects.,
Helicobacter, 12(6): p. 645-7.
94. Souza, R.C. and J.H. Lima (2009)., Helicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship., Dis Esophagus, 22(3): p. 256-63.
95. Thi Viet Ha Nguyen, Bengtsson C, Gia Khanh Nguyen, Granström M (2008)., Evaluation of a novel monoclonal-based antigen-in-stool enzyme immunoassay (Premier Platinum HpSA PLUS) for diagnosis of Helicobacter pylori infection in Vietnamese children., Helicobacter, 13(4):269-73.
96. Thi Viet Ha Nguyen, Carina Bengtsson, Gia Khanh Nguyen, Thi Thu Ha Hoang, Dac Cam Phung, Mikael Sörberg, Marta Granström (2008).,
Evaluation of two triple therapy regimens with metronidazole or clarithromycin for eradication of H. pylori infection in Vietnamese
550-556.
97. Thomas, J.E., et al (1992)., Isolation of Helicobacter pylori from human faeces., Lancet, 340(8829): p. 1194-5.
98. Tindberg, Y., et al (2001)., Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family., Gastroenterology, 121(2): p. 310-6.
99. Tolia, V., et al (2000)., Helicobacter pylori culture and antimicrobial susceptibility from pediatric patients in Michigan., Pediatr Infect Dis J, 19(12): p. 1167-71.
100. Torres, J., et al (2000)., A comprehensive review of the natural history of Helicobacter pylori infection in children., Arch Med Res, 31(5): p. 431-69.
101. Torres, J., et al (2001)., Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico., J Clin Microbiol, 39(7): p. 2677-80.
102. Vaira, D., et al (2007)., Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial., Ann Intern Med, 146(8): p. 556-63.
103. Vallve, M., et al (2002)., Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta- analysis., Aliment Pharmacol Ther, 16(6): p. 1149-56.
104. Warren, J.R (1983)., Unidentified curved bacilli on gastric epithelium in active chronic gastritis., Lancet, 1(8336): p. 1273-5.
105. Wheeldon Thục Uyên (2004)., Management of Helicobacter pylori infection in Vietnam. PhD thesis., Karolinska University, Stockhom, Sweeden.
and adults: comparative histopathologic study., Ann Diagn Pathol, 4(5): p. 279-85.
107. Xiao-Zhong Gao, Xiu-Li Qiao, Wen-Chong Song, Xiao-Feng Wang, Feng Liu (2010)., Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication., World J Gastroenterol, 14; 16(34): 4357-4362.
108. Zsikla V, Hailemariam S, Baumann M, et al (2006)., Increased rate of Helicobacter pylori infection detected by PCR in biopsies with chronic gastritis., Am J Surg Pathol, 30:242–8.
109. Zullo A, Vaira D, Vakil N, et al (2003)., High eradication rates of Helicobacter pylori with a new sequential treatment., Aliment Pharmacol Ther, 17: 719–26.
STT Họ và tên Tuổi Ngày nội soi MS 1 Nguyễn Thanh T 5 14-3-2010 10977616 2 Nguyễn Thạch T 6 26-3-2010 10047404 3 Nguyễn Minh N 5 26-3-2010 01364192 4 Nguyễn Minh P 6 26-3-2010 10048101 5 Hoàng Trung H 13 26-3-2010 10045767 6 Nguyễn Đức P 7 31-3-2010 10785778 7 Nguyễn Quỳnh T 6 3-4-2010 08009366